Identification and characterization of the molecular lesion causing mucopolysaccharidosis type I in cats

被引:37
|
作者
He, XX
Li, CM
Simonaro, CM
Wan, Q
Haskins, ME
Desnick, RJ
Schuchman, EH
机构
[1] CUNY Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA
[2] CUNY Mt Sinai Sch Med, Inst Gene Therapy & Mol Med, New York, NY 10029 USA
[3] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA
关键词
lysosomal storage diseases; animal models; mucopolysaccharidoses;
D O I
10.1006/mgme.1999.2860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mucopolysaccharidosis Type I (MPS I) is the lysosomal storage disease caused by the deficient activity of alpha-L-iduronidase (IDUA). In man, MPS I can occur in severe, mild, or intermediate forms known as the Hurler, Scheie, or Hurler/Scheie syndromes, respectively. RIPS I also has been described in cats, dogs, and mice. This manuscript reports the identification and characterization of the mutation causing RIPS I in cats. To obtain wild-type feline IDUA cDNAs, two PCR-based strategies were used. PCR primers were constructed from a conserved region of the published human and dog sequences and used to amplify a 224-bp IDUA fragment from normal cat genomic DNA. This fragment was then used to screen a feline uterus cDNA library. PCR also was used to directly amplify IDUA fragments from the same cDNA library. Two overlapping feline IDUA cDNAs encoding 466 amino acid residues of the feline IDUA polypeptide (similar to 85% of the mature protein based on comparison to the human, dog, and mouse sequences) were obtained by these strategies. To identify the mutation causing NIPS I in cats, DNA sequencing was carried out on the corresponding IDUA region from several affected animals. A 3-bp deletion was found on both IDUA alleles in each of the MPS I animals, predicting the deletion of a single aspartate residue from the feline IDUA polypeptide. To confirm the authenticity of this mutation, heteroduplex, SSCP, and transient expression studies were carried out. Over 100 animals from the RIPS I colony were screened for the presence of the mutation by heteroduplex and SSCP analyses-in all cases the presence of the 3-bp deletion was 100% concordant with the disease phenotype. For transient expression studies, the two partial, overlapping feline cDNAs were combined and joined in-frame to the 5' end of the canine IDUA cDNA. This wild-type, hybrid cDNA expressed IDUA activity up to sixfold over endogenous levels after transfection into COS-1 cells. A modified full-length IDUA cDNA containing the 3-bp deletion did not express IDUA activity in a transient expression system, providing proof that this lesion was the cause of feline MPS I. (C) 1999 Academic Press.
引用
收藏
页码:106 / 112
页数:7
相关论文
共 50 条
  • [31] CHARACTERIZATION OF MOLECULAR LESIONS CAUSING PROTEIN-C DEFICIENCY (TYPE-I AND TYPE-II)
    MARCHETTI, G
    GEMMATI, D
    PATRACCHINI, P
    CASTAMAN, G
    MORATELLI, S
    PALARETI, G
    RODEGHIERO, F
    BALLERINI, G
    BERNARDI, F
    THROMBOSIS RESEARCH, 1993, 70 : S20 - S20
  • [32] Molecular analysis of 82 mucopolysaccharidosis type I patients: Mutational spectrum in the European population and identification of 28 novel mutations
    Bertola, F.
    Parini, R.
    Casati, G.
    Tylki-Szymanska, A.
    Okur, I
    Tuysuz, B.
    Dalmau, J.
    Gonzales, Meneses A.
    Antuzzi, D.
    Barone, R.
    Dionisi, Vici C.
    Donati, A.
    Filocamo, M.
    Gabrielli, O.
    Parenti, G.
    Scarpa, M.
    Uziel, G.
    Biondi, A.
    JOURNAL OF INHERITED METABOLIC DISEASE, 2008, 31 : 108 - 108
  • [33] Evaluation and identification of IDUA gene mutations in Turkish patients with mucopolysaccharidosis type I
    Atceken, Nazente
    Ozgul, Riza Koksal
    Yilmaz, Didem Yucel
    Tokatli, Aysegul
    Coskun, Turgay
    Sivri, Hatice Serap
    Dursun, Ali
    Karaca, Mehmet
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (02) : 404 - 408
  • [34] Molecular basis of Mucopolysaccharidosis type II in Portugal: identification of four novel mutations
    da Silva, IM
    Froissart, R
    dos Santos, HM
    Caseiro, C
    Maire, I
    Bozon, D
    CLINICAL GENETICS, 2001, 60 (04) : 316 - 318
  • [35] Identification of mutation in the ARSB gene causing mucopolysaccharidosis type VI in dogs of Pembroke Welsh Corgi breed
    Lyszkowska, G.
    Grzegrzolka, B.
    Shuvar, I.
    Gruszczynska, J.
    REPRODUCTION IN DOMESTIC ANIMALS, 2024, 59
  • [36] Characterization of Surgical Procedures in Patients with Mucopolysaccharidosis Type I: Findings from the MPS I Registry
    Arn, Pamela
    Wraith, J. Edmond
    Underhill, Lisa
    JOURNAL OF PEDIATRICS, 2009, 154 (06): : 859 - 864
  • [37] Guidelines for the Management of Mucopolysaccharidosis Type I
    Martins, Ana Maria
    Dualibi, Ana Paula
    Norato, Denise
    Takata, Edna Tiemi
    Santos, Emerson S.
    Valadares, Eugenia Ribeiro
    Porta, Gilda
    de Luca, Gisele
    Moreira, Gustavo
    Pimentel, Helena
    Coelho, Janice
    Brum, Jaime Moritz
    Semionato Filho, Jose
    Kerstenetzky, Marcelo Soares
    Guimaraes, Marcia R.
    Munoz Rojas, Maria Veronica
    Aranda, Paulo Cesar
    Pires, Ricardo Flores
    Faria, Rodrigo G. C.
    Vale Mota, Ronald Moura
    Matte, Ursula
    Caldeira, Zelita
    Guedes, Ferreira
    JOURNAL OF PEDIATRICS, 2009, 155 (04): : S32 - S46
  • [38] Newborn screening of mucopolysaccharidosis type I
    Donati, Maria Alice
    Pasquini, Elisabetta
    Spada, Marco
    Polo, Giulia
    Burlina, Alberto
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2022, 59 (04) : 257 - 277
  • [39] Clinical and pathological characterization of ophthalmic disease in a canine model of mucopolysaccharidosis type I
    Nenninger, Ariel
    Ben-Shlomo, Gil
    Allbaugh, Rachel
    Valentine, Bethann
    Snella, Elizabeth
    Jens, Jackie
    Ellinwood, N. Matthew
    Smith, Jodi
    JOURNAL OF INHERITED METABOLIC DISEASE, 2023, 46 (02) : 348 - 357
  • [40] Laronidase for the treatment of mucopolysaccharidosis type I
    Clarke, Lorne A.
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2011, 6 (06) : 755 - 768